XRTX

XORTX Therapeutics Inc. - Common Stock (XRTX)

About XORTX Therapeutics Inc. - Common Stock (XRTX)

XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.

Details

Daily high

$0.97

Daily low

$0.91

Price at open

$0.92

52 Week High

$2.98

52 Week Low

$0.80

Market cap

3.5M

Dividend yield

0.00%

Volume

2,753

Avg. volume

244,748

P/E ratio

-3.17

XORTX Therapeutics Inc. - Common Stock News